文献速递艾滋病与性传播感染新发突发、热带与寄生虫病

HIV感染肝移植患者的新发癌症风险:多中心全国队列研究

De Novo Cancer in Liver Transplant Patients With HIV Infection: A Multicenter Nationwide Cohort Study.
PubMed 文献 · Clin Infect Dis · 2026-01-01

BACKGROUND: Patients with human immunodeficiency virus (HIV) infection have been gradually accepted as solid organ transplant recipients, although there is still concern that the burden of immunosuppression and HIV infection could increase the risk of post-transplant cancer.…

要点

  • 两组5年与10年累积新发癌症发病率相近(HIV阳性6%和12%,阴性6%和13%)。
  • 移植时年龄较高是唯一与新发癌症相关的因素。

核心结论

  • HIV感染本身与肝移植后新发癌症风险升高无关。

研究设计与样本

  • 西班牙多中心前瞻性队列研究,纳入272例HIV阳性与816例匹配HIV阴性肝移植受者,2002-2012年。
  • 中位随访分别为59.8个月(HIV阳性)与72.3个月(HIV阴性)。
  • 事件定义为肝移植后所有新发肿瘤,除外肝细胞癌复发和非黑色素瘤皮肤癌,死亡为竞争事件。

主要发现

  • 最常见肿瘤类型为非霍奇金淋巴瘤(n=19)、肺癌(n=14)和头颈癌(n=14)。
  • 两组肿瘤发病时间、分布及诊断时分期相似,癌症诊断后生存无差异。
  • 移植时年龄较高是唯一与新发癌症发生相关的因素。

临床怎么用

  • HIV感染不应被视为肝移植后新发癌症的独立危险因素,移植决策时可参考此证据。
  • 移植后癌症监测应关注较高年龄受者,而非仅因HIV感染加强筛查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with human immunodeficiency virus (HIV) infection have been gradually accepted as solid organ transplant recipients, although there is still concern that the burden of immunosuppression and HIV infection could increase the risk of post-transplant cancer. METHODS: The risk of de novo cancer was evaluated in a prospective cohort of 272 HIV-positive and 816 matched HIV-negative liver transplant recipients in Spain (2002-2012). All tumors, except hepatocellular carcinoma recurrence and non-melanoma skin cancer, after liver transplant were considered as events and death as competing event in this study. RESULTS: Despite matching, patients with HIV were significantly younger (45.8 vs 49.3 years). Sixteen (5.9%) patients with HIV and 61 (7.5%) HIV-negative patients developed de novo cancers (P = .39) after a median follow-up of 59.8 and 72.3 months, respectively. The most frequently diagnosed types of tumors were non-Hodgkin lymphoma (n = 19), lung cancer (n = 14), and head and neck cancer (n = 14). Time of onset, distribution, and tumor stage at diagnosis were similar in both groups. The cumulative incidences of de novo cancer at 5 and 10 years were, respectively, 6% and 12% in patients with HIV and 6% and 13% in uninfected patients. Survival after cancer diagnosis did not differ between groups. The only factor related to the development of de novo cancers was a higher age at transplantation. CONCLUSIONS: Human immunodeficiency virus infection per se is not associated to a higher risk of de novo cancer after liver transplantation.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Herrero JI, Agüero F, Manzardo C, et al. De Novo Cancer in Liver Transplant Patients With HIV Infection: A Multicenter Nationwide Cohort Study. Clin Infect Dis. 2026. PMID: 41989878. doi:10.1093/cid/ciag124

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。